Farrell, D J <br/><br/>
Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jun 2003 
 - 1777-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.47.6.1777-1783.2003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>DNA, Bacterial--chemistry<br/>Drug Resistance, Bacterial<br/>Electrophoresis, Gel, Pulsed-Field<br/>Humans<br/>Macrolides<br/>Pneumococcal Infections--microbiology<br/>Point Mutation--genetics<br/>Polymerase Chain Reaction<br/>RNA, Bacterial--chemistry<br/>RNA, Ribosomal, 23S--chemistry<br/>RNA-Binding Proteins--chemistry<br/>Ribosomal Proteins--chemistry<br/>Sequence Analysis, DNA<br/>Streptococcus pneumoniae--drug effects